169 related articles for article (PubMed ID: 28202327)
21. Synthesis and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)-methyl] derivatives of 3-aryl pyrrolidine-2,5-dione and 2-aza-spiro[4.4]nonane-1,3-dione.
Obniska J; Zagorska A
Farmaco; 2003 Dec; 58(12):1227-34. PubMed ID: 14630232
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, Anticonvulsant, and Antinociceptive Activity of New 3-(2-Chlorophenyl)- and 3-(3-Chlorophenyl)-2,5-dioxo-pyrrolidin-1-yl-acetamides.
Góra M; Czopek A; Rapacz A; Gębska A; Wójcik-Pszczoła K; Pękala E; Kamiński K
Molecules; 2021 Mar; 26(6):. PubMed ID: 33809109
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological activity of new amides derived from 3-methyl-3-phenyl-2,5-dioxo-pyrrolidin-1-yl-acetic acid.
Obniska J; Rapacz A; Rybka S; Powroźnik B; Pękala E; Filipek B; Żmudzki P; Kamiński K
Eur J Med Chem; 2015 Sep; 102():14-25. PubMed ID: 26241874
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, anticonvulsant, and antiarrhythmic properties of novel N-Mannich base and amide derivatives of β-tetralinohydantoin.
Czopek A; Byrtus H; Zagórska A; Siwek A; Kazek G; Bednarski M; Sapa J; Pawłowski M
Pharmacol Rep; 2016 Oct; 68(5):886-93. PubMed ID: 27351944
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of anticonvulsant and antinociceptive properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and 3-methylpyrrolidine-2,5-dione.
Rapacz A; Rybka S; Obniska J; Sałat K; Powroźnik B; Pękala E; Filipek B
Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):339-48. PubMed ID: 26650502
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and pharmacological evaluation of novel N-Mannich bases derived from 5,5-diphenyl and 5,5-di(propan-2-yl)imidazolidine-2,4-dione core.
Czopek A; Byrtus H; Zagórska A; Rychtyk J; Góra M; Sałat K; Rapacz A; Obniska J
Bioorg Med Chem Lett; 2019 Aug; 29(16):2387-2392. PubMed ID: 31208765
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of new of 3-(benzo[d]isoxazol-3-yl)-1-substituted pyrrolidine-2, 5-dione derivatives as anticonvulsants.
Malik S; Ahuja P; Sahu K; Khan SA
Eur J Med Chem; 2014 Sep; 84():42-50. PubMed ID: 25014748
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, and anticonvulsant activity of new amides derived from 3-methyl- or 3-ethyl-3-methyl-2,5-dioxo-pyrrolidin-1-yl-acetic acids.
Obniska J; Rapacz A; Rybka S; Góra M; Kamiński K; Sałat K; Żmudzki P
Bioorg Med Chem; 2016 Apr; 24(8):1598-607. PubMed ID: 26970661
[TBL] [Abstract][Full Text] [Related]
29. Anticonvulsant properties of N-(4-methylpiperazin-1-yl)- and N-[3-(4-methyl-piperazin-1-yl)propyl] derivatives of 3-aryl- and 3-spirocycloalkyl-pyrrolidine-2,5-dione.
Obniska J; Jurczyk S; Zejc A; Kamiński K; Tatarczyńska E; Stachowicz K
Pharmacol Rep; 2005; 57(2):170-5. PubMed ID: 15886415
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Determination of Lipophilicity, Anticonvulsant Activity, and Preliminary Safety of 3-Substituted and 3-Unsubstituted N-[(4-Arylpiperazin-1-yl)alkyl]pyrrolidine-2,5-dione Derivatives.
Rybka S; Obniska J; Żmudzki P; Koczurkiewicz P; Wójcik-Pszczoła K; Pękala E; Bryła A; Rapacz A
ChemMedChem; 2017 Nov; 12(22):1848-1856. PubMed ID: 29045762
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones.
Kamiński K; Rzepka S; Obniska J
Bioorg Med Chem Lett; 2011 Oct; 21(19):5800-3. PubMed ID: 21875804
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and evaluation of 5-substituted 1-H-tetrazoles as potent anticonvulsant agents.
Liao AM; Wang T; Cai B; Jin Y; Cheon S; Chun C; Wang Z
Arch Pharm Res; 2017 Apr; 40(4):435-443. PubMed ID: 28040846
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, physicochemical and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)alkyl]-3-phenyl- and 3-(3-methyl-phenyl)-pyrrolidine-2,5-diones.
Obniska J; Chlebek I; Pichór J; Kopytko M; Kamiński K
Acta Pol Pharm; 2009; 66(6):639-47. PubMed ID: 20050528
[TBL] [Abstract][Full Text] [Related]
34. The Search for New Anticonvulsants in a Group of (2,5-Dioxopyrrolidin-1-yl)(phenyl)Acetamides with Hybrid Structure-Synthesis and In Vivo/In Vitro Studies.
Abram M; Jakubiec M; Rapacz A; Mogilski S; Latacz G; Kamiński RM; Kamiński K
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233618
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, anticonvulsant, and antinociceptive activity of new 3-(3-methyl-2,5-dioxo-3-phenylpyrrolidin-1-yl)propanamides and 3-phenyl-butanamides.
Obniska J; Góra M; Rapacz A; Sałat K; Rybka S; Abram M; Jakubiec M; Kamiński K
Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000225. PubMed ID: 32939789
[TBL] [Abstract][Full Text] [Related]
36. Novel Mannich-bases as Potential Anticonvulsants: Syntheses, Characterization and Biological Evaluation.
Keshari AK; Tewari A; Verma SS; Saraf SK
Cent Nerv Syst Agents Med Chem; 2017; 17(3):219-228. PubMed ID: 28714383
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and anticonvulsant activity of ethyl 2,2-dimethyl-1-(2-substitutedhydrazinecarboxamido) cyclopropanecarboxylate derivatives.
Zhong M; Zhang Y; He X
Chem Biol Drug Des; 2014 Aug; 84(2):234-41. PubMed ID: 24571574
[TBL] [Abstract][Full Text] [Related]
38. Search for new potential anticonvulsants with anxiolytic and antidepressant properties among derivatives of 4,4-diphenylpyrrolidin-2-one.
Malawska K; Rak A; Gryzło B; Sałat K; Michałowska M; Żmudzka E; Lodarski K; Malawska B; Kulig K
Pharmacol Rep; 2017 Feb; 69(1):105-111. PubMed ID: 27915183
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and anticonvulsant activity of new hybrid compounds derived from 2-(2,5-dioxopyrrolidin-1-yl)propanamides and 2-(2,5-dioxopyrrolidin-1-yl)butanamides.
Kamiński K; Zagaja M; Łuszczki JJ; Rapacz A; Andres-Mach M; Latacz G; Kieć-Kononowicz K
J Med Chem; 2015 Jul; 58(13):5274-86. PubMed ID: 26052884
[TBL] [Abstract][Full Text] [Related]
40. Mechanochemical synthesis and anticonvulsant activity of 3-aminopyrrolidine-2,5-dione derivatives.
Jarzyński S; Rapacz A; Dziubina A; Pękala E; Popiół J; Piska K; Wojtulewski S; Rudolf B
Biomed Pharmacother; 2023 Dec; 168():115749. PubMed ID: 37879208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
